NLRP3 inflammasome is essential for the development of chronic obstructive pulmonary disease

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 10, 2015, Pages 13209-13216

  Yang, Wenlin ^a   Ni, Hongyan ^a   Wang, Haifeng ^a   Gu, Huiling ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Chronic obstructive pulmonary disease; Inflammasome; Nucleotide binding oligomerization domain like receptor 3

Indexed keywords

CARRIER PROTEIN; CRYOPYRIN; INFLAMMASOME; NLRP3 PROTEIN, MOUSE;

ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMASOMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85013194955     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Chronic obstructive pulmonary disease (CO-PD), World Health Organization Fact sheet no. 315; http://www.who.int/mediacentre/factsheets/fs315/en, last accessed July 22, 2015.
3. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. In: Bousquet J, Khaltaev N, editors. Geneva: WHO Press; 2007. pp. v, 15, 21.
4. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 524-6.
5. Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35: 71-86.
6. Mortaz E, Folkerts G, Nijkamp FP, Henricks PA. ATP and the pathogenesis of COPD. Eur J Pharmacol 2010; 638: 1-4.
7. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672e688.
8. dos Santos CC. The role of the inflammasome in ventilator-induced lung injury. Am J Respir Crit Care Med 2012; 185: 1141-1144.
9. Brickey WJ, Alexis NE, Hernandez ML, Reed W, Ting JP, Peden DB. Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression. J Allergy Clin Immunol 2011; 128: 900-3.
10. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V. Inflammasomes: current understanding and open questions. Cell Mol Life Sci 2011; 68: 765-83.
11. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9: 1989e1994.
12. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349e355.
13. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34: 50s-59s.
14. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32: 311-8.
15. Petersen AM, Penkowa M, Iversen M, Frydelund-Larsen L, Andersen JL, Mortensen J, Lange P, Pedersen BK. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung 2007; 185: 161-171.
16. Rovina N, Dima E, Gerassimou C, Kollintza A, Gratziou C, Roussos C. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Respir Med 2009; 103: 1056-1062.
17. Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T, Kato S, Iwasaki H, Watanabe K, Aizawa H. Interleukin-18 production and pulmonary function in COPD. Eur Respir J 2008; 31: 287-297.
18. Vande Walle L, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P, Beyaert R, Elewaut D, Kanneganti TD, van Loo G, Lamkanfi M. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 2014; 512: 69-73.
19. Brown RH, Walters DM, Greenberg RS, Mitzner W. A method of endotracheal intubation and pulmonary functional assessment for repeated studies in mice. J Appl Physiol (1985) 1999; 87: 2362-5.
20. Dhami R, Gilks B, Xie C, Zay K, Wright JL, Churg A. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. Am J Respir Cell Mol Biol 2000; 22: 244-52.
21. Wright JL, Sun JP, Vedal S. A longitudinal analysis of pulmonary function in rats during a 12 month cigarette smoke exposure. Eur Respir J 1997; 10: 1115-9.
22. Leissinger M, Kulkarni R, Zemans RL, Downey GP, Jeyaseelan S. Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection. Am J Respir Crit Care Med 2014; 189: 1461-8.
23. Hosseinian N, Cho Y, Lockey RF, Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis 2015; 9: 188-97.
24. Rotta detto Loria J, Rohmann K, Droemann D, Kujath P, Rupp J, Goldmann T, Dalhoff K. Nontypeable Haemophilus influenza infection upregulates the NLRP3 inflammasome and leads to caspase-1-dependent secretion of interleukin-1b-a possible pathway of exacerbations in COPD. PLoS One 2013; 8: e66818.
25. Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 2010; 30: 628-631.
26. Groneberg DA, Chung KF. Models of chronic obstructive pulmonary disease. Respir Res 2004; 5: 18.